Merck & Co., Inc. (MRK) — Stock analysis
USDCurrent price
118,66 USD
-1,24 USD (-1.03%) today
Market signals
About Merck & Co., Inc.
Merck & Co. is one of the largest US pharmaceutical companies (not to be confused with German Merck KGaA). Portfolio includes oncology (Keytruda/pembrolizumab — the world's best-selling cancer drug), vaccines (Gardasil 9 for HPV, Pneumovax pneumococcal vaccine), cardiovascular (Winrevair for pulmonary arterial hypertension), antivirals (Lagevrio for COVID-19) and animal health (Merck Animal Health). Headquartered in Rahway, New Jersey. DJIA component.
What does Merck & Co. do?▾
Merck & Co. makes oncology drugs (Keytruda, the world's most widely used anti-PD-1 for various cancers), vaccines (Gardasil for HPV), cardiovascular and respiratory drugs, and veterinary products (Merck Animal Health). Keytruda is the primary revenue and earnings growth driver.
Which exchange is Merck & Co. listed on?▾
Merck & Co. is listed on NYSE with ticker MRK. It is a member of the S&P 500 and Dow Jones Industrial Average.
Does Merck & Co. pay dividends?▾
Yes. It pays a progressively growing quarterly dividend. Yield is typically 2.5–3.5%.
Analyse this stock with AI
Create a free account and get 2 credits to generate a complete analysis.
Create account · 2 free credits